CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
J Stroke. 2016;18(2):169-178.   Published online May 10, 2016
DOI: https://doi.org/10.5853/jos.2016.00052

Excel Download

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo
Journal of Stroke. 2016;18(2):169-178   Crossref logo
Link1 Link2 Link3
Novel Oral Anticoagulants for Stroke Prevention in Patients with Non-valvular Atrial Fibrillation
Yoseph Rozenman, Yuri Gluzman
Atrial Fibrillation Therapy. 2013;55-89   Crossref logo
Link1
Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants
K. Kamiyama, T. Osato, H. Nakamura
Treatment of Non-vitamin K Antagonist Oral Anticoagulants. 2016;1-10   Crossref logo
Link1
Dose Selection of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Non-Valvular Atrial Fibrillation
So-Ryoung Lee, Young Keun On
Cardiovascular Prevention and Pharmacotherapy. 2020;2(1):1   Crossref logo
Link1 Link2 Link3
Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke prevention
Jay A. Montgomery, Gregory F. Michaud
Heart Rhythm. 2017;14(4):606-607   Crossref logo
Link1 Link2
Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients
Budi Yuli Setianto
ACI (Acta Cardiologia Indonesiana). 2019;5(1 (P)):17   Crossref logo
Link1 Link2
P1002Clinical Efficacy and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients with Non-Valvular Atrial Fibrillation: Results from a Nationwide Cohort Study
M S Cho, J E Yun, J J Park, Y J Kim, J Lee, D W Park, G B Nam
European Heart Journal. 2018;39(suppl_1):   Crossref logo
Link1
Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Keun-Sik Hong
Journal of Stroke. 2019;21(3):259-275   Crossref logo
Link1 Link2 Link3
Standard dose versus low dose non–vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials
Kang-Ling Wang, Robert P. Giugliano, Shinya Goto, Chun-Chih Chiu, Chun-Yi Lin, En-Yu Lai, Chern-En Chiang
Heart Rhythm. 2016;13(12):2340-2347   Crossref logo
Link1 Link2
P2569Anticoagulation plus antiplatelet therapy for atrial fibrillation: Cost-Utility of combination therapy with non-Vitamin K oral anticoagulants versus Warfarin
K Bode, G Hindricks, J Ten Berg, P Whittaker
European Heart Journal. 2018;39(suppl_1):   Crossref logo
Link1